Equity Capital Markets

Company · CIK 1720725

Oyster Point Pharma, Inc.

CIK1720725 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressNJ
Listedno ticker on SEC record today
First annual or quarterly report2019-12-03

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-249881
ShelfEffective
 2020-11-052023-01-054
333-238194
Registered companyFinal prospectus
 2020-05-122020-05-184
333-234104
IPOFinal prospectus
 2019-10-042019-10-315

Filings

15
FiledFilingRegistrationAccession
2023-01-05EFFECTDeclared effective 333-2498819999999995-23-000038
2020-12-18424B5Shelf takedown 333-2498810001193125-20-321531
2020-11-16EFFECTDeclared effective 333-2498819999999995-20-003193
2020-11-05S-3Shelf registered 333-2498810001193125-20-286956
2020-05-18424B4Final prospectus 333-2381940001193125-20-144236
2020-05-14EFFECTDeclared effective 333-2381949999999995-20-001166
2020-05-14S-1/AAmendment 333-2381940001193125-20-142919
2020-05-12S-1Registration filed 333-2381940001193125-20-140387
2020-04-27DRSDraft made public 377-031420000950123-20-003618
2019-10-31424B4Final prospectus 333-2341040001193125-19-280598
2019-10-30EFFECTDeclared effective 333-2341049999999995-19-002429
2019-10-21S-1/AAmendment 333-2341040001193125-19-270374
2019-10-15S-1/AAmendment 333-2341040001193125-19-267294
2019-10-04S-1Registration filed 333-2341040001193125-19-262771
2019-07-25DRSDraft made public 377-027500000950123-19-006616

All filings of this company · CSV